- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Amarin Corporation PLC (AMRN)
The Amarin share price today is 15.050, view NASDAQ AMRN stock exchange data. Track the latest Amarin share price with real-time updates on AMRN stock performance including market cap, day range, 52-week range and dividend yield. Access AMRN charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.820
15.100
52 wk Range
9.980
20.900
AMRN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.82015.100
52 wk Range
9.98020.900
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AMRN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
12.500
Downside
-16.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 8K AMARIN CORP PLCUK For: 29 April
- Investing.com
- Form DEF 14A AMARIN CORP PLCUK For: 10 April
- Investing.com
- Form 8K AMARIN CORP PLCUK For: 29 April
- Investing.com
- Form DEF 14A AMARIN CORP PLCUK For: 10 April
- Investing.com
- Form PRE 14A AMARIN CORP PLCUK For: 30 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
0 Buy
1 Hold
1 Sell
Ratings:
2 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 12.500
(-16.94% Downside)
Amarin Corporation PLC Earnings Call Summary for Q1/2026
- Amarin reported Q1 2026 revenue of $45.1M, up 7.4% YoY, with operating loss narrowing 32.7% to $11.3M amid 31% expense reduction.
- Company generated positive cash flow of $6.4M for second consecutive quarter, ending Q1 with $308M in cash and investments.
- U.S. Vascepa-branded prescriptions increased 17% YoY; European partnership with Recordati delivered significant revenue growth.
- Management forecasts Q2 2026 EPS of $0.54 and full-year EPS of $2.47, expecting sustained positive cash flow throughout 2026.
- CEO Thero cited restructuring success; key risks include generic competition, pricing pressures, and regulatory hurdles in international expansion.
Last Updated: 29-04-2026, 06:18 pm
Read Full TranscriptEarnings
Latest Release
25-02-2026
EPS / Forecast
-0.06 / -0.04
Revenue / Forecast
49.22M / --
Compare AMRN to Peers and Sector
Metrics to compare | AMRN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAMRNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.3x | −3.8x | −0.6x | |
PEG Ratio | −0.15 | 0.26 | 0.00 | |
Price/Book | 0.7x | 2.5x | 2.6x | |
Price / LTM Sales | 1.4x | 7.4x | 3.2x | |
Upside (Analyst Target) | −16.1% | 30.3% | 48.1% | |
Fair Value Upside | Unlock | 27.4% | 5.8% | Unlock |
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Amarin (AMRN) Share Price Today?
The Amarin share price today is 15.050.
What is the current Amarin (AMRN) share price and day range?
As of 08-05-2026, the Amarin share price is 15.050, with a previous close of 14.840. The share price has ranged from 14.820 to 15.100 today, while the 52-week range spans from 9.980 to 20.900.
What Is the Amarin Market Cap?
As of today, Amarin market cap is 311.180M.
What Is the Amarin (AMRN) Share Price Target?
The average 12-month share price target for Amarin is 12.500, with a high estimate of 13 and a low estimate of 12. 0 analysts recommend buying, while 1 suggest selling, with an overall rating of Sell and -16.94% Downside potential.
What Is Amarin's Earnings Per Share (TTM)?
The Amarin EPS (TTM) is -1.610.
From a Technical Analysis Perspective, Is AMRN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Amarin Trade On?
Amarin is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Amarin?
The stock symbol for Amarin is "AMRN."
How Many Times Has Amarin Stock Split?
Amarin has split 3 times.
How Many Employees Does Amarin Have?
Amarin has 80 employees.
What Is the AMRN After Hours Price?
AMRN's last after hours stock price is 15.280, the stock has changed by 0.230, or 1.530%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.